🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

BioNTech SE

BNTX Healthcare
$96.06 $-2.6 (-2.64%)
Market Cap: $24.13 B
Gurus Holding
2
Popularity Rank
#3626
% of Shares Held
0.18%
Net Activity (Q2 2026)
+$30.26 M

Guru Ownership Trend

Guru Analysis for BioNTech SE (BNTX)

BioNTech SE (BNTX), a key player in the Healthcare sector, continues to attract institutional attention.

As of Q2 2026, a total of 2 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $44.24 M.

Top institutional holders include Steven Cohen and Catherine Wood.

Institutional sentiment is currently Bullish. This is evidenced by a $30.26 M net inflow during the quarter.

Recent activity highlights Steven Cohen who opened a new position.

Key Holders

Top 5 by Value

$30.44 M
$12.41 M

Top 5 by Conviction

Recent Activity Breakdown (Q2 2026)

+$30.95 M
Total Buy Value
New Buys 1
Additions 1
-$689,531
Total Sell Value
Reductions 0
Sold Out 1

Guru Consensus (Q2 2026)

Based on recent activity
Net Sellers
1
Net Buyers
2

FAQs for BioNTech SE (BNTX)

Major holders include Steven Cohen ($30.44 M), Catherine Wood ($12.41 M). According to the latest reported data, 2 tracked investment managers collectively hold approximately 460,517 shares.

According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $30.26 M, with 2 managers increasing positions and 1 managers reducing holdings.

During the most recent reporting period, 0 managers trimmed their positions, while 1 fully exited BNTX. The total reported sell value was $689,531.

Yes, 1 managers opened new positions in BNTX, and 1 increased their existing holdings. The total reported buy value was $30.95 M.

Portfolio Manager % Portfolio Activity Shares Value Report Date
0.03% New Buy 327,184 $30.44 M Q2 2026
0.08% Add 4.3% 133,333 $12.41 M Q2 2026
Date
Insider Name
Transaction
Value
Shares
Position / Chg
SEC Form